Compare $KTTA vs $PTN | Chartloom

Compare

$KTTA vs $PTN

Pasithea Therapeutics Corp · Palatin Technologies Inc

KTTA

Pasithea Therapeutics Corp

PTN

Palatin Technologies Inc

Compare $KTTA vs $PTN

Comparing Pasithea Therapeutics Corp and Palatin Technologies Inc

KTTAPasithea Therapeutics Corp

PTNPalatin Technologies Inc

KTTAPasithea Therapeutics Corp

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

740.5%

YTD performance

-60.7%

52W performance

-43.0%

FCF yield

-113.8%

PTNPalatin Technologies Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

3581.2%

YTD performance

-46.4%

52W performance

19.6%

FCF yield

-88.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KTTA

PTN

Detailed metrics comparison

KTTA

Pasithea Therapeutics Corp

PTN

Palatin Technologies Inc

Market Cap

KTTA$16M

PTN$15M

Enterprise Value

KTTA$-30M

PTN$8M

Price

KTTA$0.47

PTN$8.60

P/E Ratio

KTTAN/A

PTNN/A

P/S Ratio

KTTA26.84x

PTN1.16x

EV/Sales

KTTA0.00x

PTN0.59x

EV/EBITDA

KTTA0.00x

PTN0.18x

P/B Ratio

KTTA0.32x

PTN1.57x

P/FCF Ratio

KTTAN/A

PTNN/A

EV/FCF

KTTA1.69x

PTN-0.58x

PEG Ratio

KTTAN/A

PTNN/A

Forward P/E (NTM)

KTTAN/A

PTNN/A

Forward P/S (NTM)

KTTAN/A

PTNN/A

Revenue (TTM)

KTTA$0

PTN$13M

Revenue Growth (YoY)

KTTA740.5%

PTN3581.2%

Forward Rev Growth

KTTA0.0%

PTN-58.6%

Gross Margin (TTM)

KTTA100.5%

PTN97.8%

Operating Margin (TTM)

KTTA0.0%

PTN0.0%

EBITDA Margin (TTM)

KTTA0.0%

PTN-65.3%

Net Margin (TTM)

KTTA0.0%

PTN-63.5%

FCF Margin (TTM)

KTTAN/A

PTN-103.0%

Net Income (TTM)

KTTA$-21M

PTN$-8M

FCF (TTM)

KTTA$-18M

PTN$-14M

EPS (TTM)

KTTA-$0.66

PTN-$2.14

ROE (TTM)

KTTA-4949.0%

PTN-5370.0%

ROA (TTM)

KTTA-4681.0%

PTN-5808.0%

ROIC (TTM)

KTTA-4949.0%

PTN-5370.0%

Cash

KTTA$46M

PTN$7M

Debt

KTTA$0

PTN$0

Net Cash/Debt

KTTA$46M

PTN$7M

Current Ratio (TTM)

KTTA26.25x

PTN5.04x

Quick Ratio (TTM)

KTTA24.91x

PTN4.93x

Debt/Equity (TTM)

KTTA0.00x

PTN2.00x

Debt/Assets (TTM)

KTTA0.0%

PTN0.0%

Interest Coverage (TTM)

KTTAN/A

PTNN/A

Net Debt/EBITDA (TTM)

KTTA0.00x

PTN0.00x

Beta

KTTA0.39

PTN0.84

52W Performance

KTTA-43.0%

PTN19.6%

YTD Performance

KTTA-60.7%

PTN-46.4%

% from 52W High

KTTA-77.3%

PTN-72.3%

% from 52W Low

KTTA66.4%

PTN53.3%

Asset Turnover (TTM)

KTTA0.01x

PTN0.97x

FCF Yield (TTM)

KTTA-113.8%

PTN-88.7%

Earnings Yield (TTM)

KTTA-136.3%

PTN-54.7%

Dividend Yield (TTM)

KTTAN/A

PTNN/A

Rule of 40

KTTA740.5

PTN3,478.2

EV/GP/RG

KTTAN/A

PTNN/A

Ticker research

View KTTA research View PTN research

Metric	KTTA Pasithea Therapeutics Corp	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$16M	$15M
Enterprise Value	$-30M	$8M
Price	$0.47	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	26.84x	1.16x
EV/Sales	0.00x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	0.32x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	1.69x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$13M
Revenue Growth (YoY)	740.5%	3581.2%
Forward Rev Growth	0.0%	-58.6%
Profitability
Gross Margin (TTM)	100.5%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-65.3%
Net Margin (TTM)	0.0%	-63.5%
FCF Margin (TTM)	N/A	-103.0%
Net Income (TTM)	$-21M	$-8M
FCF (TTM)	$-18M	$-14M
EPS (TTM)	-$0.66	-$2.14
ROE (TTM)	-4949.0%	-5370.0%
ROA (TTM)	-4681.0%	-5808.0%
ROIC (TTM)	-4949.0%	-5370.0%
Financial Health
Cash	$46M	$7M
Debt	$0	$0
Net Cash/Debt	$46M	$7M
Current Ratio (TTM)	26.25x	5.04x
Quick Ratio (TTM)	24.91x	4.93x
Debt/Equity (TTM)	0.00x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	0.84
52W Performance	-43.0%	19.6%
YTD Performance	-60.7%	-46.4%
% from 52W High	-77.3%	-72.3%
% from 52W Low	66.4%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.97x
FCF Yield (TTM)	-113.8%	-88.7%
Earnings Yield (TTM)	-136.3%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	740.5	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View KTTA research	View PTN research

Valuation

P/S Ratio

PTN

1.16x

KTTA

26.84x

EV/FCF

PTN

-0.58x

KTTA

1.69x

Growth & revenue

Revenue Growth TTM

PTN

3581.2%

KTTA

740.5%

Forward Revenue Growth

KTTA

0.0%

PTN

-58.6%

Profitability & performance

Gross Margin

KTTA

100.5%

PTN

97.8%

ROE

KTTA

-4949.0%

PTN

-5370.0%

FCF Yield %

PTN

-88.7%

KTTA

-113.8%

52-Week Performance

PTN

19.6%

KTTA

-43.0%

Detailed metrics comparison

KTTA

Pasithea Therapeutics Corp

PTN

Palatin Technologies Inc

Market Cap

KTTA$16M

PTN$15M

Enterprise Value

KTTA$-30M

PTN$8M

Price

KTTA$0.47

PTN$8.60

P/E Ratio

KTTAN/A

PTNN/A

P/S Ratio

KTTA26.84x

PTN1.16x

EV/Sales

KTTA0.00x

PTN0.59x

EV/EBITDA

KTTA0.00x

PTN0.18x

P/B Ratio

KTTA0.32x

PTN1.57x

P/FCF Ratio

KTTAN/A

PTNN/A

EV/FCF

KTTA1.69x

PTN-0.58x

PEG Ratio

KTTAN/A

PTNN/A

Forward P/E (NTM)

KTTAN/A

PTNN/A

Forward P/S (NTM)

KTTAN/A

PTNN/A

Revenue (TTM)

KTTA$0

PTN$13M

Revenue Growth (YoY)

KTTA740.5%

PTN3581.2%

Forward Rev Growth

KTTA0.0%

PTN-58.6%

Gross Margin (TTM)

KTTA100.5%

PTN97.8%

Operating Margin (TTM)

KTTA0.0%

PTN0.0%

EBITDA Margin (TTM)

KTTA0.0%

PTN-65.3%

Net Margin (TTM)

KTTA0.0%

PTN-63.5%

FCF Margin (TTM)

KTTAN/A

PTN-103.0%

Net Income (TTM)

KTTA$-21M

PTN$-8M

FCF (TTM)

KTTA$-18M

PTN$-14M

EPS (TTM)

KTTA-$0.66

PTN-$2.14

ROE (TTM)

KTTA-4949.0%

PTN-5370.0%

ROA (TTM)

KTTA-4681.0%

PTN-5808.0%

ROIC (TTM)

KTTA-4949.0%

PTN-5370.0%

Cash

KTTA$46M

PTN$7M

Debt

KTTA$0

PTN$0

Net Cash/Debt

KTTA$46M

PTN$7M

Current Ratio (TTM)

KTTA26.25x

PTN5.04x

Quick Ratio (TTM)

KTTA24.91x

PTN4.93x

Debt/Equity (TTM)

KTTA0.00x

PTN2.00x

Debt/Assets (TTM)

KTTA0.0%

PTN0.0%

Interest Coverage (TTM)

KTTAN/A

PTNN/A

Net Debt/EBITDA (TTM)

KTTA0.00x

PTN0.00x

Beta

KTTA0.39

PTN0.84

52W Performance

KTTA-43.0%

PTN19.6%

YTD Performance

KTTA-60.7%

PTN-46.4%

% from 52W High

KTTA-77.3%

PTN-72.3%

% from 52W Low

KTTA66.4%

PTN53.3%

Asset Turnover (TTM)

KTTA0.01x

PTN0.97x

FCF Yield (TTM)

KTTA-113.8%

PTN-88.7%

Earnings Yield (TTM)

KTTA-136.3%

PTN-54.7%

Dividend Yield (TTM)

KTTAN/A

PTNN/A

Rule of 40

KTTA740.5

PTN3,478.2

EV/GP/RG

KTTAN/A

PTNN/A

Ticker research

View KTTA research View PTN research

Metric	KTTA Pasithea Therapeutics Corp	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$16M	$15M
Enterprise Value	$-30M	$8M
Price	$0.47	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	26.84x	1.16x
EV/Sales	0.00x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	0.32x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	1.69x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$13M
Revenue Growth (YoY)	740.5%	3581.2%
Forward Rev Growth	0.0%	-58.6%
Profitability
Gross Margin (TTM)	100.5%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-65.3%
Net Margin (TTM)	0.0%	-63.5%
FCF Margin (TTM)	N/A	-103.0%
Net Income (TTM)	$-21M	$-8M
FCF (TTM)	$-18M	$-14M
EPS (TTM)	-$0.66	-$2.14
ROE (TTM)	-4949.0%	-5370.0%
ROA (TTM)	-4681.0%	-5808.0%
ROIC (TTM)	-4949.0%	-5370.0%
Financial Health
Cash	$46M	$7M
Debt	$0	$0
Net Cash/Debt	$46M	$7M
Current Ratio (TTM)	26.25x	5.04x
Quick Ratio (TTM)	24.91x	4.93x
Debt/Equity (TTM)	0.00x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	0.84
52W Performance	-43.0%	19.6%
YTD Performance	-60.7%	-46.4%
% from 52W High	-77.3%	-72.3%
% from 52W Low	66.4%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.97x
FCF Yield (TTM)	-113.8%	-88.7%
Earnings Yield (TTM)	-136.3%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	740.5	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View KTTA research	View PTN research